No real need for introduction Swisscom. It is by far the largest Swiss telecommunications company, privatized from the former federal PTT. The Swiss Confederation is still the majority shareholder. Swisscom provides telecommunications services not only in Switzerland, but also in Italy, via its company Fastweb. It has 20,000 employees.
Let's say it bluntly and straight away: Swisscom shares are currently very expensive compared to what we can expect from them. Those who have followed my latest analyses on certain Japanese stocks will immediately realize the gigantic gulf between the two.
SCMN is trading at 16.9 times recurring earnings. So far, so good. On the American and European markets, we currently find much worse. On the other hand, it is trading at 117 times tangible book value, 2.32 times sales and 18.7 times free cash flow. We are very far from the figures we had on Japanese stocks...
If we look at the dividend, at first glance, it might seem much more interesting, with a yield of 4.2%. However, such "generosity" is explained by a distribution ratio of 71.3%, which leaves little room for a future increase in the dividend and also preterites the company's investment intentions in the development of its business. Worse, a drop in profits could at least partially threaten the dividend. If we look back a little, we can see that it is no longer increasing, while earnings per share are eroding. The same goes for cash reserves and asset values... they are falling in the long term. In short, it doesn't smell very good.
Cash reserves are low, with a current ratio of only 0.89 (down) and a reduced liquidity ratio of only 0.85. Fortunately it is "Swisscom" because with such figures we would fear defaults at lesser-known companies that do not have the government in the background. On the gross margin side it is much better, since it is very large and increasing, at 83%. At the same time, if a company of this type, with still a more or less monopolistic situation does not have a large margin (net margin 14%), that would worry me. The return on assets is also attractive, with 7.5% (up), for a return on equity of 14.4%. Here too these are very good figures and can be explained by the activity and the particular situation of the Swiss company.
On the debt side, however, things are getting worse, with a long-term debt ratio to assets of 32.9%. Even if the debt tends to decrease slightly in the long term, it remains high. It would take Swisscom almost six years to pay off all its debt using all of its free cash flow...
It should also be noted that Swisscom has not sought to finance itself by increasing its capital, the number of shares in circulation having not changed for several years, which is positive.
Swisscom is certainly a real institution in Switzerland, still enjoying a pseudo monopoly, with the government always in the background. However, even if this particular situation helps it in terms of margin and profitability, other fundamentals of the company are not optimal. This is all the more true if we look at them in relation to the price that must be paid to acquire the share.
So I have just parted ways with Swisscom.
Discover more from dividendes
Subscribe to get the latest posts sent to your email.
I also sold my Swisscom shares a few weeks ago, as you said: too expensive, too much debt, no growth in earnings and therefore in dividends.
Another very interesting analysis. I find that between dividinde and you, Jérôme, there is a lot of excellent new content.
Regarding Swisscom, I think your analysis will help me to get rid of it. I bought it when the stock went down last year. The gain on price is 13%. Not huge, but always good to take profits. Indeed, apart from a big dividend that I consider quite safe, it does not seem that the future is promising. I am asking for growth, not necessarily Alibaba-style, but a minimum of growth. The question arises as to which other Swiss stock to replace Swisscom with. I would be interested in Emmi, Jungfraubahn, Lindt, Roche, Bell, BVZ. The first two are too expensive for my taste, the third is worse. BVZ seems the best in terms of valuation.
What do you think?
Thank you JL for your compliments, it always makes me happy.
It is true that the arrival of dividinde has done some good. He has a more Swiss and more Buffet approach than me. So we complement each other well 😉
As far as I'm concerned, I unfortunately think that none of the titles you mention can be recommended for purchase at this time.
The question that remains to be answered is: if we have some, should we sell them?
I did this for JFN, and I will decide after the annual results for Bell, Emmi and BVZ. I must say that I love these three stocks which are all baggers in my portfolio. I will do an analysis this spring for these three.
Thank you JL and Jérôme. I also really appreciate Jérôme's analyses because he is interested in other titles than me and comparing different opinions is always enriching to open your mind (and sometimes also enriching for the wallet).
It is becoming almost mission impossible to find Swiss stocks that are not overpriced at the moment, without buying anything (like Rieter or Aryzta). In your list, there is only Roche that I find affordable at the moment, even if its valuation depends a lot on important decisions by the FDA in the coming months. I am just going to buy myself a block of stone... er, Roche next week.
Otherwise I bought Schweiter and LLB last week and I am patiently watching BFW to find a slightly lower entry level.
Thanks for your answers. No rush to buy of course. Roche is rated undervalued by Morningstar and now dividinde. I will take a closer look at this as it is one of my favorite stocks.
Roche's stock price is worth more than 80 times its tangible book value and 22 times its earnings.
This can be partly explained by the fact that
1) a large part of the company's value comes from its know-how, but if we take into account intangibles we are still at 10 times the book value...
2) the company's margin and profitability are very good
So it's way too expensive for a Graham-oriented investor and possibly accessible for a more Buffet-oriented investor...
In terms of dividends, be careful of the generous yield of 3%, because it comes at the cost of a payout of 70% and growth of only 3% per year on average.
It is normal that the dividend has difficulty increasing, earnings per share have been flat for several years...
You will have understood, I am not a fan 🙂
Oh no, I wouldn't say undervalued, just not overvalued, which is already not so bad in a bull market like this. And the dividend is correct, safe and at least slightly increasing.
Be careful with Roche, most financial sites (even SIX's!) give truncated figures because they miss its particular capital structure! This is really a dirty trap that made me miss Roche at first. Indeed, the capital is made up of dividend certificates (approx. 80%) and bearer shares.
Fortunately, there is for example Finanz und Wirtschaft which gives the right ratios. In reality, the 2017 PER is 16 and the 2018 PER estimated at 15. The price-to-book ratio is around 9-10 and the payout ratio is 56.4%.
Good accuracy! But still a bit too expensive for me.
Great, thanks for your analysis, which I also share.
I also saw that you are gradually reducing your US exposure. Is this also why we can no longer access the US Dividends 5+ page?
No. I have another problem with another provider. I'll try to fix it, but I'm not sure I'll succeed... Free data in finance is definitely becoming increasingly rare...
Swisscom's profit forecast to drop... Let's just say we're not too surprised!
Holy shit I hadn't been to see the class anymore...